ML
Molecular Partners AG
MLLCF · OTC
$4.01 +0.00% (+$0.00)
Market Cap CHF 122.9M
P/E Ratio -
Div. Yield -
ROE 58.26%
Bulios Fair Price
$2.31
42.4% downside
Current Price
$4.01
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MLLCF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
93 /100
Cheap P/B 1.79x
EV/EBITDA N/A
P/S N/A
Growth
0 /100
Declining Book val. growth 30.08%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 58.26%
ROA 58.21%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 9.42x
Int. coverage -2,056.00x
Debt/Equity 0.05x
Stability
28 /100
Unstable Rev. volatility 39.74%
EPS volatility 92.48%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MLLCF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Patrick Amstutz
Employees
149
Headquarters
Schlieren
Upcoming events
29 OCT
Earnings
Upcoming earnings report